Huadong Medicine Co., Ltd
000963
Classement en actions
#2706
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Prix de l'action
$3.89
Capitalisation boursière
$6.83B
Changement (1 jour)
-2.22%
Changement (1 an)
-30.58%
Pays
CN
Échange Huadong Medicine Co., Ltd (000963)
Catégorie
Healthcare
Ratio P/S pour Huadong Medicine Co., Ltd (000963)
Ratio P/S au October 2026 TTM : 1.04
Selon les derniers rapports financiers et le cours de l'action de Huadong Medicine Co., Ltd, le ratio cours/ventes actuel (TTM) est 1.04. À la fin de 2024, le ratio P/S était de 1.45.
Historique du ratio P/S pour Huadong Medicine Co., Ltd de 2001 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 1.04 | -34.83% |
| 2025 | 1.59 | 9.57% |
| 2024 | 1.45 | -19.08% |
| 2023 | 1.79 | -17.67% |
| 2022 | 2.17 | 6.69% |
| 2021 | 2.04 | 47.50% |
| 2020 | 1.38 | 14.65% |
| 2019 | 1.20 | 5.83% |
| 2018 | 1.14 | -39.88% |
| 2017 | 1.89 | 38.15% |
| 2016 | 1.37 | -16.29% |
| 2015 | 1.64 | 35.51% |
| 2014 | 1.21 | 0.71% |
| 2013 | 1.20 | 18.17% |
| 2012 | 1.01 | -2.10% |
| 2011 | 1.04 | -34.93% |
| 2010 | 1.59 | 55.30% |
| 2009 | 1.03 | 32.57% |
| 2008 | 0.77 | -50.74% |
| 2007 | 1.57 | 227.06% |
| 2006 | 0.48 | 27.11% |
| 2005 | 0.38 | -21.59% |
| 2004 | 0.48 | -19.33% |
| 2003 | 0.60 | -11.17% |
| 2002 | 0.67 | -8.68% |
| 2001 | 0.74 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 2.82 | 171.75% |
DE
|
|
| 3.02 | 191.24% |
DE
|
|
| 2.19 | 111.04% |
JP
|
|
| 8.92 | 760.91% |
CH
|
|
| 7.04 | 579.46% |
IN
|
